Chu-Chi Lin

788 total citations
7 papers, 280 citations indexed

About

Chu-Chi Lin is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Chu-Chi Lin has authored 7 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Epidemiology. Recurrent topics in Chu-Chi Lin's work include Immunotherapy and Immune Responses (4 papers), Immune Response and Inflammation (2 papers) and RNA Interference and Gene Delivery (2 papers). Chu-Chi Lin is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Immune Response and Inflammation (2 papers) and RNA Interference and Gene Delivery (2 papers). Chu-Chi Lin collaborates with scholars based in Taiwan, China and United States. Chu-Chi Lin's co-authors include Jian‐Tai Qiu, Hsi‐Chien Huang, Shu‐Yi Lin, Fu‐Fei Hsu, Kuan‐Wei Huang, Yu‐Ting Huang, Chih‐Chun Chang, Yu-Chuan Shih, Yung‐Chang Lin and Yun‐Chieh Sung and has published in prestigious journals such as Analytical Chemistry, Science Advances and Vaccine.

In The Last Decade

Chu-Chi Lin

7 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chu-Chi Lin Taiwan	5	124	118	101	64	52	7	280
Mahdieh Shokrollahi Barough Iran	11	125 1.0×	112 0.9×	80 0.8×	44 0.7×	74 1.4×	31	326
Thijs J. Beldman Netherlands	6	121 1.0×	157 1.3×	74 0.7×	46 0.7×	53 1.0×	8	330
Susanne Melzer Germany	10	113 0.9×	75 0.6×	121 1.2×	56 0.9×	28 0.5×	17	361
Shardool Jain United States	5	122 1.0×	122 1.0×	75 0.7×	63 1.0×	24 0.5×	8	313
Karina Kinghorn United States	7	152 1.2×	71 0.6×	89 0.9×	63 1.0×	78 1.5×	9	319
Chandra Kumar Elechalawar United States	11	159 1.3×	50 0.4×	156 1.5×	154 2.4×	50 1.0×	12	376
Anne Showalter United States	4	141 1.1×	122 1.0×	96 1.0×	19 0.3×	119 2.3×	6	350
Bolei Dai China	7	171 1.4×	281 2.4×	224 2.2×	74 1.2×	101 1.9×	11	500
Chih-Chun Chang Taiwan	8	123 1.0×	149 1.3×	147 1.5×	93 1.5×	100 1.9×	14	429

Countries citing papers authored by Chu-Chi Lin

Since Specialization

Citations

This map shows the geographic impact of Chu-Chi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chu-Chi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chu-Chi Lin more than expected).

Fields of papers citing papers by Chu-Chi Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chu-Chi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chu-Chi Lin. The network helps show where Chu-Chi Lin may publish in the future.

Co-authorship network of co-authors of Chu-Chi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chu-Chi Lin. A scholar is included among the top collaborators of Chu-Chi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chu-Chi Lin. Chu-Chi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lin, Chu-Chi, et al.. (2025). Conglomerated Imiquimod and Metronidazole Incorporated Biodegradable Nanofibrous Mats for Potential Therapy of Cervical Cancer. International Journal of Nanomedicine. Volume 20. 951–966. 1 indexed citations

2.

Lin, Chu-Chi, et al.. (2021). Enhancing immunogenicity of HPV16 E7 DNA vaccine by conjugating codon-optimized GM-CSF to HPV16 E7 DNA. Taiwanese Journal of Obstetrics and Gynecology. 60(4). 700–705. 3 indexed citations

3.

Huang, Kuan‐Wei, Fu‐Fei Hsu, Jian‐Tai Qiu, et al.. (2020). Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer. Science Advances. 6(3). eaax5032–eaax5032. 213 indexed citations

4.

Lin, Chu-Chi, Chun‐Bing Chen, Chuang‐Wei Wang, Wen‐Hung Chung, & Wen‐Hung Chung. (2020). Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies. Expert Review of Clinical Immunology. 16(4). 373–387. 23 indexed citations

5.

Qiu, Jian‐Tai, et al.. (2019). Effect of Multiple Vaccinations with Tumor Cell-Based Vaccine with Codon-Modified GM-CSF on Tumor Growth in a Mouse Model. Cancers. 11(3). 368–368. 8 indexed citations

6.

Lin, Chu-Chi, et al.. (2015). The efficacy of a novel vaccine approach using tumor cells that ectopically express a codon-optimized murine GM-CSF in a murine tumor model. Vaccine. 34(1). 134–141. 13 indexed citations

7.

Chen, Hsiao‐Chien, Jian‐Tai Qiu, Fu-Liang Yang, et al.. (2014). Magnetic-Composite-Modified Polycrystalline Silicon Nanowire Field-Effect Transistor for Vascular Endothelial Growth Factor Detection and Cancer Diagnosis. Analytical Chemistry. 86(19). 9443–9450. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact